News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Harold Burstein: ER-low tumors will require chemotherapy and endocrine therapy
Photo from Harold Burstein/X
Apr 30, 2024, 12:22

Harold Burstein: ER-low tumors will require chemotherapy and endocrine therapy

Harold Burstein, Breast Cancer Specialist and Professor at Dana Farber Cancer Institute, shared a post by Annals of Surgical Oncology on X/Twitter, adding:

”Key clinical takeaway is that in contemporary breast cancer pathology, most ER-low (< 10%) tumors will require chemotherapy and endocrine therapy.”

Quoting Annals of Surgical Oncology’s post:

”April Issue: Defining the Biology of Estrogen Receptor-Low-Positive.”

Harold Burstein: ER-low tumors will require chemotherapy and endocrine therapy

Source: Harold Burstein/X and AnnalsSurgOncology/X

Annals of Surgical Oncology Breast Cancer cancer chemotherapy Dana-Farber Cancer Institute endocrine therapy ER-low tumors Harold Burstein OncoDaily Oncology
Special Coverage
Blog
Dec 22, 2024, 05:17
Rasha Aboelhassan: Oncologists are overwhelmed by their own fights against cancer
Blog
Dec 22, 2024, 05:15
Jemma Arakelyan: Collaboration plans between City University of Hong Kong and Shenzhen Hospital of Southern Medical University
Blog
Dec 22, 2024, 05:13
The Connell and O’Reilly Families Cell Manipulation Core Facility at Dana-Farber Cancer Institute
Blog
Dec 22, 2024, 05:05
Ruben Mesa: Excited to visit Atrium Health Levine Cancer Pineville
Blog
Dec 22, 2024, 05:02
Muhammad Umair Mushtaq: Are Stem Cell Transplants Safe for Myelofibrosis Patients Over 70?
Blog
Dec 22, 2024, 05:00
Elvina Almuradova: Being a part of Giuseppe Curigliano's team is an invaluable scientific milestone for me
Blog
Dec 22, 2024, 04:58
Summary slide for PFS in selected trials by IGHV status caveat for CLL by Nitin Jain
Insight
Dec 22, 2024, 04:53
Cancer survivors are growing in number - National Cancer Institute
Blog
Dec 22, 2024, 04:52
Registration is open for the ESMO Gastrointestinal Cancers Congress 2025
Blog
Dec 22, 2024, 04:49
Amalya Sargsyan: New ESO Rare Cancer Series podcast with Salvatore Provenzano
Insight
Dec 22, 2024, 04:47
Journal of Psychosocial Oncology Research and Practice: Vol. 6, Number 4 - IPOS
Science
Dec 22, 2024, 04:40
The prevalence of widespread guideline-discordant LDCT screening in a low-risk population by So Yeon Kim et al.